Practice Management
Buprenorphine—used to treat opioid use disorder—is the only drug that ever came with federal limits on the number of patients a provider could care for. It also came with restrictions on the types of clinicians who could prescribe it. Rules requiring the so-called “x-waiver” for prescribing clinicians were ultimately repealed in December 2022. Since then, providers have been able to offer buprenorphine to any number of patients who need addiction treatment and a path to …
Read More
Click Here to download the PDF. Urgent message: In December 2022, Congress passed the Mainstreaming Addiction Treatment Act (W-Waiver), which would remove federal patient caps and allow any healthcare provider with a standard DEA controlled-medication license to prescribe buprenorphine. Alan A. Ayers, MBA, MAcc is Senior Editor of The Journal of Urgent Care Medicine and President of Experity Consulting. For over a decade, the question of whether or not to prescribe buprenorphine/naloxone (Suboxone) products in urgent …
Read More